Your browser doesn't support javascript.
loading
Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study.
Nava-Valdivia, C A; Ponce-Guarneros, J M; Saldaña-Cruz, A M; Corona-Sanchez, E G; Ramirez-Villafaña, M; Perez-Guerrero, E E; Murillo-Saich, J D; Contreras-Haro, B; Vazquez-Villegas, M L; Gonzalez-Ponce, F; Bonilla-Lara, D; Jacobo-Cuevas, H; Centeno-Valadez, J D; Echeverria-Gonzalez, G; Cerpa-Cruz, S; Alcaraz-Lopez, M F; Cardona-Muñoz, E G; Salazar-Paramo, M; Gonzalez-Lopez, L; Gamez-Nava, J I.
Afiliação
  • Nava-Valdivia CA; Departamento de Microbiología y Patología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Ponce-Guarneros JM; Unidad Médica Familiar 97, Instituto Mexicano del Seguro Social (IMSS), 46470 Magdalena, JAL, Mexico.
  • Saldaña-Cruz AM; Instituto de Terapéutica Experimental y Clínica (INTEC), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Corona-Sanchez EG; Instituto de Terapéutica Experimental y Clínica (INTEC), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Ramirez-Villafaña M; Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Perez-Guerrero EE; Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Murillo-Saich JD; Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Contreras-Haro B; Instituto de Investigación en Ciencias Biomédicas (IICB), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Vazquez-Villegas ML; Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.
  • Gonzalez-Ponce F; Departamento de Ciencias Biomédicas, Centro Universitario de Tonalá, Universidad de Guadalajara, 45425 Tonalá, JAL, Mexico.
  • Bonilla-Lara D; Programa de Doctorado en Ciencias de la Salud Pública, Departamento de Salud Pública, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Jacobo-Cuevas H; Programa de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Centeno-Valadez JD; Programa de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Echeverria-Gonzalez G; Programa de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Cerpa-Cruz S; Departamento de Reumatología, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, 44329 Guadalajara, JAL, Mexico.
  • Alcaraz-Lopez MF; Departamento de Reumatología, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, 44329 Guadalajara, JAL, Mexico.
  • Cardona-Muñoz EG; División de Reumatología, Hospital Civil de Guadalajara "Fray Antonio Alcalde", 44280, Guadalajara, JAL, Mexico.
  • Salazar-Paramo M; Departamento de Medicina Interna-Reumatología, Hospital General Regional 46, IMSS, 44910 Guadalajara, JAL, Mexico.
  • Gonzalez-Lopez L; Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
  • Gamez-Nava JI; Programa de Doctorado en Farmacología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico.
Biomed Res Int ; 2021: 5567666, 2021.
Article em En | MEDLINE | ID: mdl-34497849
ABSTRACT

BACKGROUND:

Fracture risk assessment tool (FRAX) index was developed for estimating of the 10-year risk of major or hip osteoporotic fracture. To date, there is insufficient information regarding the correlation between FRAX and serum bone turnover markers (BTMs), such as soluble ligand of receptor activator of nuclear factor-κB (sRANKL), osteoprotegerin (OPG), and other molecules related with secondary osteoporosis in rheumatoid arthritis (RA). Therefore, this study is aimed at assessing the correlation between the FRAX and serum levels of sRANKL, OPG, sRANKL/OPG ratio, Dickkopf-1 (DKK-1), and sclerostin (SOST) in RA.

METHODS:

Cross-sectional study included 156 postmenopausal women with RA. Bone mineral density (BMD) was measured at lumbar spine (L1-L4) and total hip using dual-energy X-ray absorptiometry (DXA). RA patients were divided into (A) RA + osteoporosis and (B) RA without osteoporosis. FRAX scores were calculated including the total hip BMD. Serum sRANKL, OPG, DKK-1, and SOST levels were measured by ELISA. Pearson tests were used for assessing the correlation between serum levels of these molecules and FRAX scores in RA.

RESULTS:

The RA + osteoporosis group had elevated sRANKL levels (p = 0.005), higher sRANKL/OPG ratio (p = 0.017), decreased DKK-1 (p = 0.028), and lower SOST levels (p < 0.001). Low total hip BMD correlated with high sRANKL (p = 0.001) and sRANKL/OPG ratio (p = 0.005). Total hip and lumbar spine BMD correlated with DKK-1 (p = 0.009 and p = 0.05, respectively) and SOST levels (p < 0.001 and p < 0.001, respectively). Higher sRANKL levels and sRANKL/OPG ratio correlated with estimated 10-year risk of a major osteoporotic fractures (p = 0.003 and p = 0.003, respectively) and hip fracture (p = 0.002 and p = 0.006, respectively). High serum SOST levels were associated with a low estimated 10-year risk of a major osteoporotic fracture (p = 0.003) and hip fracture (p = 0.009).

CONCLUSION:

High sRANKL levels and sRANKL/OPG ratio can be useful to detect a subgroup of RA patients who has an increased 10-year risk of major and hip osteoporotic fractures.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Artrite Reumatoide / Remodelação Óssea / Ligante RANK / Osteoprotegerina / Fraturas por Osteoporose Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Biomed Res Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Artrite Reumatoide / Remodelação Óssea / Ligante RANK / Osteoprotegerina / Fraturas por Osteoporose Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Biomed Res Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: México